Defend your patients' wounds between weekly debridements 
with PuraPly AM

Only PuraPly AM has the power of plus: The unique combination of native, cross-linked ECM + broad-spectrum PHMB that provides a sustained antimicrobial barrier to keep you in command of the healing environment all week long.1-3

ECM=extracellular matrix; PHMB=polyhexamethylene biguanide

KEY BARRIERS 
TO HEALING

The inability and/or unwillingness of patients to adhere to treatment plans for chronic wounds can impede healing. However, healthcare studies show that patient adherence improves when treatments require less intervention.4

LEARN MORE ABOUT PATIENT NONCOMPLIANCE

Excessive wound bioburden and biofilm trigger a continuous inflammatory response that stalls healing.5

LEARN MORE ABOUT BIOBURDEN & BIOFILM

The inability and/or unwillingness of patients to adhere to treatment plans for chronic wounds can impede healing. However, healthcare studies show that patient adherence improves when treatments require less intervention.4

LEARN MORE ABOUT PATIENT NONCOMPLIANCE

Excessive wound bioburden and biofilm trigger a continuous inflammatory response that stalls healing.5

LEARN MORE ABOUT BIOBURDEN & BIOFILM

CHOOSE
NEXT-LEVEL
CONTROL WITH
PURAPLY AM

Early bioburden management with sharp debridement plus PuraPly AM puts you in immediate command of the healing environment.1,2,6-8

WHY PURAPLY AM
PuraPly AM product shot

READY TO TAKE CONTROL OF 
THE HEALING ENVIRONMENT?

Talk to an Organogenesis Tissue Regeneration Specialist about the advanced antimicrobial barrier with native, cross-linked ECM + broad-spectrum PHMB.

Contact us

CONFIRMATION
OF CONTROL

Examine the scientific and real-world studies that demonstrate the effectiveness of PuraPly AM.

SCIENTIFIC EVIDENCE
REAL-WORLD EVIDENCE
Components that make up the Organogenesis Circle of Care program

Organogenesis' Circle of Care is a comprehensive program that provides the highest-quality customer service and reimbursement support. Our wide range of expertise includes:

VIEW ALL SERVICES

REFERENCES:

  1. Data on file. PDR-0001. Organogenesis Inc.
  2. Data on file. PDR-0002. Organogenesis Inc.
  3. PuraPly Antimicrobial [package insert]. Canton, MA: Organogenesis Inc; 2015.
  4. Atreja A, et al. MedGenMed. 2005;7(1):4.
  5. Frykberg RG, et al. Adv Wound Care. 2015;4(9):560-582.
  6. Hübner NO, et al. Skin Pharmacol Physiol. 2010;23(1 suppl):17-27.
  7. Brantley J, et al. Wounds Int. 2016;7(3):1-5.
  8. Gilbert P, et al. J Appl Microbiol. 2005;99(4):703-715.